Precision Biosciences Executives Sell Shares Amid Market Volatility.
ByAinvest
Thursday, Jan 22, 2026 6:52 pm ET1min read
DTIL--
Precision Biosciences Inc. has announced that Michael Amoroso, Director, President and CEO, has sold 34,799 shares at $4.17 per share on January 22, 2026. Additionally, John Alexander Kelly, Chief Financial Officer, has sold 15,213 shares at $4.03 per share on January 21, 2026. Dario Scimeca, General Counsel and Secretary, has sold 8,854 shares at $4.03 per share on the same date. Jefferson J. Smith, Chief Research Officer, has also sold 10,200 shares at $4.03 per share on January 21, 2026.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet